NEW YORK, Oct. 30 - Molecular Staging’s microarray-based protein-detection and -amplification technology is as accurate as traditional tests for allergen specific IgE, according to results of a recent study .

New Haven, Conn.-based MSI is developing this technology, called Rolling Circle Amplification Technology, for use in a protein-chip approach to diagnostics. MSI is currently working on applications in immunodiagnostic and gene-based diagnostic markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.